SCHEMBL29944864

SCHEMBL29944864

CCOC(=O)c1cccc(NC(=O)c2sccc2S(=O)(=O)N(c2ccc(OCC)cc2)C(C)C)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SREBF1 P36956 9/20 0.72
NR1H3 Q13133 7/20 0.72
NR1H2 P55055 7/20 0.72
MAPT P10636 5/20 0.53
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
ALDH1A1 P00352 3/20 0.50
MAPK1 P28482 2/20 0.50
LMNA P02545 2/20 0.50
HSD17B10 Q99714 2/20 0.50
POLB P06746 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TSHR P16473 1/20 0.49
CA12 O43570 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27245342 1.00 SREBF1 (0.72) SREBF1NR1H3NR1H2MAPTNPC1
SCHEMBL27030489 0.91 SREBF1 (0.61) SREBF1NR1H3NR1H2MAPTNPC1
SCHEMBL27030601 0.90 SREBF1 (0.89) SREBF1NR1H3NR1H2MAPTNPC1
SCHEMBL27030659 0.85 SREBF1 (0.76) SREBF1NR1H3NR1H2MAPTNPC1
SCHEMBL29944868 0.85 SREBF1 (0.80) SREBF1NR1H3NR1H2MAPTNPC1
SCHEMBL27245333 0.85 SREBF1 (0.80) SREBF1NR1H3NR1H2MAPTNPC1
SCHEMBL27030539 0.84 SREBF1 (1.00) SREBF1NR1H3NR1H2MAPTNPC1
SCHEMBL27245378 0.84 SREBF1 (0.89) SREBF1NR1H3NR1H2MAPTNPC1
SCHEMBL27245358 0.83 SREBF1 (0.85) SREBF1NR1H3NR1H2MAPTNPC1
SCHEMBL29944859 0.83 SREBF1 (0.89) SREBF1NR1H3NR1H2MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308554-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA The Board of Trustees of the University of Illinois (US) 2024-01-24 EP disclosed
WO-2022197658-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2022-09-22 WO disclosed